Cardiol Therapeutics's total assets for Q4 2025 were C$23.62M, an increase of 82.42% from the previous quarter. TSE:CRDL total liabilities were C$5.74M for the fiscal quarter, a 69.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.